Previous close | 6.83 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | 126.098M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.58 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
EQS-News: BRAIN Biotech AG / Key word(s): AGM/EGMResolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG 08.03.2023 / 17:20 CET/CESTThe issuer is solely responsible for the content of this announcement.Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG Executive Board and Supervisory Board discharged with large majority Large majorities in the re-election of one member to the Supervisory Board and the elec
BRAIN Biotech ( ETR:BNN ) First Quarter 2023 Results Key Financial Results Revenue: €14.1m (up 36% from 1Q 2022). Net...
EQS-News: BRAIN Biotech AG / Key word(s): Capital Markets DayCapital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion 27.02.2023 / 16:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion Strategy: building a successful international multi-niche enzyme and food ingredients champion Performance